Table 1.
Study | Publication Year | No. of Patients | Mean or Median Follow-Up (months) | Mean or Median Margin Dose (Gy) | Radiographic Tumor Control (%) |
---|---|---|---|---|---|
Feigl et al19 | 2002 | 61 | 55.2 | 15 | 94 |
Sheehan et al28 | 2002 | 42 | 31.2 | 16 | 97.6 |
Wowra et al29 | 2002 | 30 | 57.7 | 16 | 93.3 |
Petrovich et al26 | 2003 | 52 | 34 | 15 | 100 |
Losa et al23 | 2004 | 54 | 41.1 | 16.6 | 96.3 |
Muacevic et al25 | 2004 | 51 | 21.7 | 16.5 | 95 |
Kajiwara et al22 | 2005 | 14 | 32.1 | 12.6 | 92.9 |
Picozzi et al27 | 2005 | 51 | 40.6 | 16.5 | 96.1 |
Iwai et al21 | 2005 | 28 | 36.4 | 12.3 | 93 |
Mingione et al24 | 2006 | 100 | 46.4 | 18.5 | 92.2 |
Voges et al41 | 2006 | 37 | 56.6 | 13.4 | 100 |
Liscak et al36 | 2007 | 140 | 60 | 20 | 100 |
Pollock et al38 | 2008 | 62 | 64 | 16 | 96.8 |
Hoybye et al20 | 2009 | 23 | 78 | 20 | 100 |
Kobayashi et al35 | 2009 | 71 | 50.2 | NR | 96.7 |
Castro et al30 | 2010 | 14 | 42 | 12.5 | 100 |
Hayashi et al33 | 2010 | 43 | 36 | 18.2 | 100 |
Gopalan et al32 | 2011 | 48 | 95 | 18.4 | 83 |
Iwata et al34 | 2011 | 100 | 33 | 21 Gy/3 fr, 25 Gy/5 fr | 98 |
Park et al37 | 2011 | 125 | 62 | 13 | 90 |
El-Shehaby et al31 | 2012 | 21 | 44 | 12 | 85 |
Runge et al39 | 2012 | 65 | 83 | 13 | 98.3 |
Starke et al40 | 2012 | 140 | 50.4 | 18 | 90 |
Wilson et al42 | 2012 | 51 | 50 | 14 | 100 |
Sheehan et al43 | 2013 | 512 | 36 | 16 | 93 |
Abbreviations: fr, fraction; NR, not reported.